DiaSorin S.p.A.

BIT:DIA Stock Report

Market Cap: €5.3b

DiaSorin Past Earnings Performance

Past criteria checks 3/6

DiaSorin's earnings have been declining at an average annual rate of -3.2%, while the Medical Equipment industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 10.8% per year. DiaSorin's return on equity is 11.6%, and it has net margins of 16%.

Key information

-3.2%

Earnings growth rate

-4.9%

EPS growth rate

Medical Equipment Industry Growth8.3%
Revenue growth rate10.8%
Return on equity11.6%
Net Margin16.0%
Next Earnings Update14 Mar 2025

Recent past performance updates

Recent updates

Is DiaSorin (BIT:DIA) A Risky Investment?

Nov 29
Is DiaSorin (BIT:DIA) A Risky Investment?

DiaSorin S.p.A. (BIT:DIA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 08
DiaSorin S.p.A. (BIT:DIA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

DiaSorin S.p.A. (BIT:DIA) Investors Are Less Pessimistic Than Expected

Aug 23
DiaSorin S.p.A. (BIT:DIA) Investors Are Less Pessimistic Than Expected

DiaSorin S.p.A. (BIT:DIA) Just Released Its Interim Results And Analysts Are Updating Their Estimates

Aug 01
DiaSorin S.p.A. (BIT:DIA) Just Released Its Interim Results And Analysts Are Updating Their Estimates

We Think DiaSorin (BIT:DIA) Can Stay On Top Of Its Debt

Jul 16
We Think DiaSorin (BIT:DIA) Can Stay On Top Of Its Debt

DiaSorin's (BIT:DIA) Dividend Will Be Increased To €1.15

Apr 09
DiaSorin's (BIT:DIA) Dividend Will Be Increased To €1.15

DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

Mar 25
DiaSorin (BIT:DIA) Is Paying Out A Larger Dividend Than Last Year

DiaSorin S.p.A. (BIT:DIA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Mar 20
DiaSorin S.p.A. (BIT:DIA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 19% Below Its Share Price

Feb 17
DiaSorin S.p.A.'s (BIT:DIA) Intrinsic Value Is Potentially 19% Below Its Share Price

Is DiaSorin (BIT:DIA) Using Too Much Debt?

Jan 25
Is DiaSorin (BIT:DIA) Using Too Much Debt?

Revenue & Expenses Breakdown

How DiaSorin makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BIT:DIA Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,17818941888
30 Jun 241,16116841688
31 Mar 241,14716441490
31 Dec 231,14816041491
30 Sep 231,19515041493
30 Jun 231,25218842097
31 Mar 231,29320042098
31 Dec 221,36124141597
30 Sep 221,39128541097
30 Jun 221,40830239193
31 Mar 221,32931534680
31 Dec 211,23831130570
30 Sep 211,13031525857
30 Jun 211,01430322349
31 Mar 2197328821951
31 Dec 2088124821751
30 Sep 2079121221352
30 Jun 2073818621450
31 Mar 2071017321449
31 Dec 1970617621348
30 Sep 1970016821246
30 Jun 1968816120946
31 Mar 1967516020645
31 Dec 1866915820145
30 Sep 1866316119745
30 Jun 1864915419244
31 Mar 1864414518945
31 Dec 1763714018844
30 Sep 1762512518543
30 Jun 1762212518343
31 Mar 1760212117841
31 Dec 1656911217038
30 Sep 1654411116434
30 Jun 1652010615830
31 Mar 1650610215527
31 Dec 1549910015426
30 Sep 154869515125
30 Jun 154729314825
31 Mar 154558714425
31 Dec 144448414025
30 Sep 144378413925
30 Jun 144328213724
31 Mar 144358213724
31 Dec 134358313624

Quality Earnings: DIA has high quality earnings.

Growing Profit Margin: DIA's current net profit margins (16%) are higher than last year (12.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DIA's earnings have declined by 3.2% per year over the past 5 years.

Accelerating Growth: DIA's earnings growth over the past year (26%) exceeds its 5-year average (-3.2% per year).

Earnings vs Industry: DIA earnings growth over the past year (26%) did not outperform the Medical Equipment industry 26%.

Return on Equity

High ROE: DIA's Return on Equity (11.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:30
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DiaSorin S.p.A. is covered by 28 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sumit SayalAlphaValue
Paola SagliettiBanca Akros S.p.A. (ESN)
Gaurav JainBarclays